
TGFβRI-IN-3
CAS No. 2763602-67-9
TGFβRI-IN-3( —— )
Catalog No. M37631 CAS No. 2763602-67-9
TGFβRI-IN-3 is a highly selective TGFβR1 inhibitor with an IC50 of 0.79 nM and exhibits 2000-fold selectivity against MAP4K4, showing potential applications in immuno-oncology .
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 122 | In Stock |
![]() ![]() |
5MG | 187 | In Stock |
![]() ![]() |
10MG | 297 | In Stock |
![]() ![]() |
25MG | 564 | In Stock |
![]() ![]() |
50MG | 879 | In Stock |
![]() ![]() |
100MG | 1233 | In Stock |
![]() ![]() |
500MG | 2457 | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameTGFβRI-IN-3
-
NoteResearch use only, not for human use.
-
Brief DescriptionTGFβRI-IN-3 is a highly selective TGFβR1 inhibitor with an IC50 of 0.79 nM and exhibits 2000-fold selectivity against MAP4K4, showing potential applications in immuno-oncology .
-
DescriptionTGFβRI-IN-3 inhibits TGFβR1 at an IC50 of 0.79 nM with 2000-fold selectivity against MAP4K4. TGFβRI-IN-3 represents a highly selective TGFβR1 inhibitor that has potential applications in immuno-oncology.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorTGF-beta/Smad
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2763602-67-9
-
Formula Weight465.57
-
Molecular FormulaC28H23N3O2S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (107.40 mM; Ultrasonic (<60°C)
-
SMILESN(C=1C2=C(C=C(C=C2)C3=CC=C(S(C)(=O)=O)C=C3)N=CC1)C=4C=C(N=CC4)C5=CC(C)=CC=C5
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Kharbanda A, et al. Discovery of 4-aminoquinolines as highly selective TGFβR1 inhibitors with an attenuated MAP4K4 profile for potential applications in immuno-oncology [published online ahead of print, 2021 Aug 12]. Eur J Med Chem. 2021;225:113763.?
molnova catalog



related products
-
LR-90
LR-90 is also used in the research of diabetic animal model.LR-90 is an advanced glycation end product (AGE) inhibitor, inhibits inflammatory responses in human monocytes.?
-
EURYCOMANONE
Eurycomanone is cytotoxic on HepG2 cells by inducing apoptosis through the up-regulation of p53 and Bax, and down-regulation of Bcl-2.
-
GW 610
GW 610 is an antitumor benzothiazole that shows growth-inhibitory activity against several cancer cell lines.